New research has highlighted the risk of gastric illnesses associated with 15 different types of GLP-1 drugs commonly prescribed for Type II diabetes and weight loss management.
Many of the incidents involved overdoses with compounded versions of Ozempic and Wegovy's active ingredient, semaglutide.
Domperidone is a drug used to treat stomach paralysis, which has been linked to Ozempic. However, researchers warn that side effects may increase a diabetic's risk of cardiac arrest by 66%
Bendectin contains dicyclomine, an active ingredient used in the anti-nausea drug thalidomide, which was linked to severe birth defects.
The stroke risk for Reglan and similar drugs was higher within the first few days of starting treatment, researchers warn.
